Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
What If a COVID Vaccine Were Available Tomorrow?
With COVID cases on the rise in many countries, the race to find an effective vaccine is becoming a more pressing concern every day. The pharmaceutical company Pfizer has just announced that they have succesfully produced a COVID-19 vaccine in the lab which is 95% effective against the virus.
Be warned: Check your insurance before getting a COVID-19 vaccine this year
Planning on getting the new COVID-19 shot? Check your insurance first 03:11. The Centers for Disease Control and Prevention says that the Food and Drug Administration has ended a
Planning on getting the new COVID-19 shot? Check your insurance first
The Centers for Disease Control and Prevention says that the Food and Drug Administration has ended a program that provided free COVID-19 vaccines in August of 2024. Because of that, some are warned to double-check your insurance before getting the shot.
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to
1d
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
1d
S.A. had a COVID-19 summer and the winter surge is next. Can the new vaccine slow it?
A summer wave of cases locally and across the country may be on the decline and a vaccine targeting the latest variants is ...
1d
Pfizer, BioNTech's Omicron-Adapted Covid-19 Vaccine Gets E.U. Marketing Recommendation
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
Northwest Asian Weekly
1d
Fight off the virus this fall with a 2024-2025 COVID-19 vaccine
It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.
Hosted on MSN
2d
Pfizer Stock Rises 7.3% in 3 Months: Should You Invest Now?
Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has ...
2d
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
4d
FDA OKs third dose for Pfizer and Moderna Covid-19 vaccines
These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...
23h
Pfizer Advances On Its Cancer Journey
Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...
Medscape
19h
EU OKs Meningococcal Disease Vaccine
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
12d
Pfizer Quietly Gaining Momentum
KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...
The American Journal of Managed Care
3d
New RSV Vaccine Is Likely Cost-Effective for Older Adults, Study Finds
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
1d
on MSN
The time to act on COVID vaccines and flu shots? Soon, Evansville hospitals say
Flu season approaches and there's a new COVID variant. The time to act is now, or soon, according to the two largest local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback